Biobanking - Collaborating for Global R&D and Investment

Event details

11th - 12th July 2011
Crowne Plaza - The City

About the event

In an age of austerity, biobanks are increasing in number; the UK government alone committed a large sum of money – in the region of £250m - to develop future research initiatives and with leading pharmaceutical companies worldwide also continuing to invest in R&D, biobanks continue to prove pivotal for future drug discoveries.


Faced with fantastic commercial growth opportunities, issues are continuing to resonate within biobanking with international regulations, patient consent, quality of samples, and attracting investors, proving to be the key stumbling blocks. SMi's Biobanking conference tackles these issues with a fresh perspective: join our unique forum today to discover innovative research from leading pharma, understand the true logistics behind a successful biobank and develop partnerships to ensure you are implementing frameworks for a globalisation of biobanks.


Biobanking 2011 is SMi’s inaugural event, acting as a bridge between the worlds leading academia and pharma, this truly is a perfect opportunity to market with an extremely targeted delegate audience that will be making a huge difference in future drug discovery.


Key Note Speakers Include:

  • Julia Corfield, Biobank Head, AstraZeneca
  • George Tokiwa, Associate Scientific Director, Merck
  • Dr Rivka Ravid, Senior Scientist, Royal Dutch Academy of Sciences, Brain Bank Consultants
  • Nigel Spurr, Biomarker Expert, Roche
  • Dr Sven Kili, Global Medical Director – Cell Therapy & Regenerative Medicine, Genzyme
  • David Pulford, Investigator Genertics Capabilities for EU & Asia / Japan, GlaxoSmithKline


Benefits of Attending Include:

  • A comprehensive understanding of the pitfalls and practicilaties of biobanking on a day-to-day basis
  • A thorough analysis of collaborative biobanking - developing communication frameworks
  • Insight into successful development and implementation of new technologies
  • Exploring the commercial opportunities that global regulations present
  • Assesing the importance of quality control
  • Analyse the different regulations in place for independent certification organisations and self regulating biobanks
  • Participate in interactive discussions and our fantastic post-conference workshop